Bristol-Myers Squibb (United States)

686.8k citations
16.0k papers ·

Impact in

  • Immunology top 1%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Cancer Immunotherapy and Biomarkers 964
    • CAR-T cell therapy research 569

Bristol-Myers Squibb (United States)

14.6k papers receiving 613.4k citations

Peers

Bristol-Myers Squibb (United States)
Comparison fields: 5 of 245
  • Immunology 93.0k
  • Oncology 113.6k
  • Hepatology 26.1k
  • Pharmaceutical Science 22.3k
  • Hematology 30.5k
Replace Pfizer (United States) with:
Pfizer (United States) United States
Merck & Co., Inc., Rahway, NJ, USA (United States) United States
United States Food and Drug Administration United States
National Heart Lung and Blood Institute United States
National Institute of Diabetes and Digestive and Kidney Diseases United States
GlaxoSmithKline (United States) United States
Center for Cancer Research United States
Sidney Kimmel Comprehensive Cancer Center United States
Roswell Park Comprehensive Cancer Center United States
Cancer Research Institute United States
Bristol-Myers Squibb (United States) relative to Pfizer (United States) United States Pfizer (United States)'s profile →
Citations per field
00.5×1.7×
Pfizer (United States) · 1×
Citations per year

Countries citing scholars working at Bristol-Myers Squibb (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Bristol-Myers Squibb (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Bristol-Myers Squibb (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bristol-Myers Squibb (United States) more than expected).

Fields of papers published by authors at Bristol-Myers Squibb (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Bristol-Myers Squibb (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Bristol-Myers Squibb (United States) at the time of their publication.

About Bristol-Myers Squibb (United States)

In recent decades, authors affiliated with Bristol-Myers Squibb (United States) have published 16.0k papers, which have received a total of 686.8k indexed citations . Scholars at this organization have produced 3.2k papers in Oncology, 1.1k papers in Hematology, 1.7k papers in Immunology, 765 papers in Genetics and 478 papers in Pharmaceutical Science on the topics of Cancer Immunotherapy and Biomarkers (964 papers), Monoclonal and Polyclonal Antibodies Research (849 papers), HIV/AIDS drug development and treatment (576 papers), CAR-T cell therapy research (569 papers), Protein purification and stability (560 papers), Analytical Chemistry and Chromatography (549 papers), Chemical Synthesis and Analysis (487 papers) and Chronic Lymphocytic Leukemia Research (408 papers). Their work is cited by papers focused on Immunology (93.0k citations), Oncology (113.6k citations), Hepatology (26.1k citations), Pharmaceutical Science (22.3k citations) and Hematology (30.5k citations). Authors at Bristol-Myers Squibb (United States) collaborate with scholars in United States, Germany and United Kingdom and have published in prestigious journals including Journal of Clinical Oncology, Bioorganic & Medicinal Chemistry Letters, Blood, Annals of Oncology and Tetrahedron Letters. Some of Bristol-Myers Squibb (United States)'s most productive authors include Nicholas A. Meanwell, Mariano Barbacid, Alejandro Aruffo, Peter S. Linsley, Abu T.M. Serajuddin, Jeffrey A. Ledbetter, R Bravo, J A Ledbetter, Ramesh N. Patel and Mohammed Jemal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact